Bavarian Nordic

Contact
bavarian-nordic.com
+498985650030

Bavarian Nordic GmbH

Fraunhoferstrasse 13
82152 Martinsried
Germany
+498985650030
bavarian-nordic.com
Contact
Profile Products News
Contact

About Bavarian Nordic

Bavarian Nordic (CSE: BAVA) is a leading international biopharmaceutical company developing and producing innovative vaccines to prevent and treat infectious diseases and cancer. With operations in Denmark, Germany, the USA, and Singapore, Bavarian Nordic employs over 260 people.

Read more about Bavarian Nordic
Facts about Bavarian Nordic
  • Focus : Manufacturer
  • Employees: 501-1,000
  • Industry : Pharma

Product portfolio of Bavarian Nordic

Product portfolio

Show all

News about Bavarian Nordic

Bavarian Nordic

18-Nov-2011 | research and development

Bavarian Nordic Initiates Pivotal Phase 3 Trial of PROSTVAC Prostate Cancer Immunotherapy

Bavarian Nordic A/S announced that its subsidiary, BN ImmunoTherapeutics has initiated the pivotal Phase 3 trial of PROSTVAC® for patients with asymptomatic ...

Read news
Bavarian Nordic

14-Nov-2011 | research and development

Bavarian Nordic's Immunotherapy Product Candidate CV-301 Shows Promise in Breast and Ovarian Cancer

Bavarian Nordic A/S  announced that encouraging clinical trial results with CV-301 in patients with metastatic breast or ovarian cancer were published in ...

Read news
Bavarian Nordic

11-Oct-2011 | business & finance

Bavarian Nordic Obtains Rights to New Cancer Vaccine Product Candidates

Bavarian Nordic A/S announced that its BN ImmunoTherapeutics subsidiary has entered into an expanded strategic partnership with the National Cancer ...

Read news
Bavarian Nordic

02-Sep-2011 | business & finance

Bavarian Nordic awards warrants to board, management and certain employees

Bavarian Nordic A/S  announced that the Board of Directors in Bavarian Nordic has decided to award warrants to management, certain employees in the Company ...

Read news
Bavarian Nordic

10-Mar-2011 | science

Bavarian Nordic Enters Into New Research Project to Develop New Cancer Vaccines

Bavarian Nordic A/S announced that the Company will participate in a new Danish research project, established with the purpose of identifying pathogens ( ...

Read news
Bavarian Nordic

02-Mar-2011 | research and development

Bavarian Nordic Announces Start of Randomized Phase 2 Study Comparing PROSTVAC and Chemotherapy versus Chemotherapy

Bavarian Nordic A/S announced the initiation of a new multicenter, randomized Phase 2 study of patients with metastatic castration-resistant prostate ...

Read news
Bavarian Nordic

18-Oct-2010 | research and development

Bavarian Nordic Receives NIH Grant to Investigate the Potential of an MVA-BN based Vaccine against Ebola and Marburg Viruses

Bavarian Nordic A/S announced that the company has received funding from the U.S. National Institutes of Health (NIH) to advance its early research in ...

Read news
Bavarian Nordic

14-Oct-2010 | business & finance

US Government Exercises Next Part of Bavarian Nordic's Freeze-Dried IMVAMUNE Contract

Bavarian Nordic A/S announced that BARDA (Biomedical Advanced Research and Development Authority) has exercised the next option under the contract for the ...

Read news
Show more news about Bavarian Nordic

Here you will find Bavarian Nordic GmbH